Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120247

Author :

Publish date : 2026-03-10 21:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Senator to Investigate FDA Rejections of Rare Disease Drugs

FDA Reverses Stance on Leucovorin for Autism

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

Related Posts

Antidepressant Reduces Meth Addiction in Trial

Review Highlights Factors Behind ADHD and Autism Rise

Delivering a Multiple Myeloma Diagnosis With Clarity and Compassion

Americans Say Trump Hasn’t Done Enough to Make America Healthy Again

Be the Quarterback: How to Manage Stuttering in Children

Trader Joe’s Recall; 450 Hospitals May Close or Cut Services; ‘Rib Remodeling’ Trend

Antidepressant Reduces Meth Addiction in Trial

Review Highlights Factors Behind ADHD and Autism Rise

Delivering a Multiple Myeloma Diagnosis With Clarity and Compassion

Americans Say Trump Hasn’t Done Enough to Make America Healthy Again

Be the Quarterback: How to Manage Stuttering in Children

Trader Joe’s Recall; 450 Hospitals May Close or Cut Services; ‘Rib Remodeling’ Trend

‘Would I have made it to 60 if my cancer symptoms weren’t detected?’

5 Factors May Predict Stroke Risk Years After First Event

Categories

Archives